These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

838 related items for PubMed ID: 18166835

  • 1. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.
    Inamura K, Takeuchi K, Togashi Y, Nomura K, Ninomiya H, Okui M, Satoh Y, Okumura S, Nakagawa K, Soda M, Choi YL, Niki T, Mano H, Ishikawa Y.
    J Thorac Oncol; 2008 Jan; 3(1):13-7. PubMed ID: 18166835
    [Abstract] [Full Text] [Related]

  • 2. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
    Wallander ML, Geiersbach KB, Tripp SR, Layfield LJ.
    Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.
    Takahashi T, Sonobe M, Kobayashi M, Yoshizawa A, Menju T, Nakayama E, Mino N, Iwakiri S, Sato K, Miyahara R, Okubo K, Manabe T, Date H.
    Ann Surg Oncol; 2010 Mar; 17(3):889-97. PubMed ID: 20183914
    [Abstract] [Full Text] [Related]

  • 4. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
    Boland JM, Erdogan S, Vasmatzis G, Yang P, Tillmans LS, Johnson MR, Wang X, Peterson LM, Halling KC, Oliveira AM, Aubry MC, Yi ES.
    Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
    [Abstract] [Full Text] [Related]

  • 5. EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas.
    Shinmura K, Kageyama S, Tao H, Bunai T, Suzuki M, Kamo T, Takamochi K, Suzuki K, Tanahashi M, Niwa H, Ogawa H, Sugimura H.
    Lung Cancer; 2008 Aug; 61(2):163-9. PubMed ID: 18242762
    [Abstract] [Full Text] [Related]

  • 6. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.
    Shaozhang Z, Xiaomei L, Aiping Z, Jianbo H, Xiangqun S, Qitao Y.
    Genes Chromosomes Cancer; 2012 Oct; 51(10):925-32. PubMed ID: 22736493
    [Abstract] [Full Text] [Related]

  • 7. EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFR.
    Wu SG, Kuo YW, Chang YL, Shih JY, Chen YH, Tsai MF, Yu CJ, Yang CH, Yang PC.
    J Thorac Oncol; 2012 Jan; 7(1):98-104. PubMed ID: 22124476
    [Abstract] [Full Text] [Related]

  • 8. New insights into anaplastic lymphoma kinase-positive nonsmall cell lung cancer.
    Dubey AP, Pathi N, Viswanath S, Rathore A, Pathak A, Sud R.
    Indian J Cancer; 2017 Jan; 54(1):203-208. PubMed ID: 29199691
    [Abstract] [Full Text] [Related]

  • 9. Effective enrichment strategy for EML4-ALK fusion gene screening in patients with non-small cell lung cancer.
    Kobayashi M, Sakakibara T, Inoue A, Fukuhara T, Sasano H, Ichinose M, Nukiwa T.
    Respir Investig; 2014 Jan; 52(1):49-56. PubMed ID: 24388371
    [Abstract] [Full Text] [Related]

  • 10. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
    Lin E, Li L, Guan Y, Soriano R, Rivers CS, Mohan S, Pandita A, Tang J, Modrusan Z.
    Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
    [Abstract] [Full Text] [Related]

  • 11. ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity.
    Kimura H, Nakajima T, Takeuchi K, Soda M, Mano H, Iizasa T, Matsui Y, Yoshino M, Shingyoji M, Itakura M, Itami M, Ikebe D, Yokoi S, Kageyama H, Ohira M, Nakagawara A.
    Lung Cancer; 2012 Jan; 75(1):66-72. PubMed ID: 21757253
    [Abstract] [Full Text] [Related]

  • 12. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.
    Wong DW, Leung EL, So KK, Tam IY, Sihoe AD, Cheng LC, Ho KK, Au JS, Chung LP, Pik Wong M, University of Hong Kong Lung Cancer Study Group.
    Cancer; 2009 Apr 15; 115(8):1723-33. PubMed ID: 19170230
    [Abstract] [Full Text] [Related]

  • 13. A novel EML4-ALK variant: exon 6 of EML4 fused to exon 19 of ALK.
    Penzel R, Schirmacher P, Warth A.
    J Thorac Oncol; 2012 Jul 15; 7(7):1198-9. PubMed ID: 22706607
    [Abstract] [Full Text] [Related]

  • 14. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.
    Takeuchi K, Choi YL, Soda M, Inamura K, Togashi Y, Hatano S, Enomoto M, Takada S, Yamashita Y, Satoh Y, Okumura S, Nakagawa K, Ishikawa Y, Mano H.
    Clin Cancer Res; 2008 Oct 15; 14(20):6618-24. PubMed ID: 18927303
    [Abstract] [Full Text] [Related]

  • 15. Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component.
    Yoshida A, Tsuta K, Watanabe S, Sekine I, Fukayama M, Tsuda H, Furuta K, Shibata T.
    Lung Cancer; 2011 Jun 15; 72(3):309-15. PubMed ID: 21036415
    [Abstract] [Full Text] [Related]

  • 16. HIP1-ALK, a novel ALK fusion variant that responds to crizotinib.
    Fang DD, Zhang B, Gu Q, Lira M, Xu Q, Sun H, Qian M, Sheng W, Ozeck M, Wang Z, Zhang C, Chen X, Chen KX, Li J, Chen SH, Christensen J, Mao M, Chan CC.
    J Thorac Oncol; 2014 Mar 15; 9(3):285-94. PubMed ID: 24496003
    [Abstract] [Full Text] [Related]

  • 17. Non-small cell lung cancer with EML4-ALK translocation in Chinese male never-smokers is characterized with early-onset.
    Guo Y, Ma J, Lyu X, Liu H, Wei B, Zhao J, Fu S, Ding L, Zhang J.
    BMC Cancer; 2014 Nov 18; 14():834. PubMed ID: 25407901
    [Abstract] [Full Text] [Related]

  • 18. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.
    Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H.
    Nature; 2007 Aug 02; 448(7153):561-6. PubMed ID: 17625570
    [Abstract] [Full Text] [Related]

  • 19. Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer.
    Sanders HR, Li HR, Bruey JM, Scheerle JA, Meloni-Ehrig AM, Kelly JC, Novick C, Albitar M.
    Cancer Genet; 2011 Jan 02; 204(1):45-52. PubMed ID: 21356191
    [Abstract] [Full Text] [Related]

  • 20. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.
    To KF, Tong JH, Yeung KS, Lung RW, Law PP, Chau SL, Kang W, Tong CY, Chow C, Chan AW, Leung LK, Mok TS.
    J Thorac Oncol; 2013 Jul 02; 8(7):883-91. PubMed ID: 23625156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.